Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3SSC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,924
Award facts
- Contract value 100% obligated
- $12,924.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,924.07 for Dupixent 300 mg/2 ml pen injections on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a direct pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs.
This delivery order falls under AmerisourceBergen's prime Indefinite Delivery Vehicle (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Dupixent is a specialty pharmaceutical product used in the treatment of atopic dermatitis and other immunological conditions, reflecting the company's role in delivering specialized medical commodities to Defense Health Agency and other federal healthcare systems. As a non-set-aside award, this contract demonstrates AmerisourceBergen's continued capability to compete successfully for federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F3SSC?
SPE2DR26F3SSC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F3SSC worth?
The government has obligated $12,924 on SPE2DR26F3SSC.
Is contract SPE2DR26F3SSC an order under another contract?
Yes. SPE2DR26F3SSC is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SSC competed?
The extent of competition for SPE2DR26F3SSC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award